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Abstract Tenecin 1, an inducible antibacterial protein secreted
in the larvae of Tenebrio molitor, has a long N-terminal loop and
common structural feature of insect defensin family correspond-
ing to cysteine stabilized K/L motif. To study the function of the
N-terminal loop and disulfide bridges, N-terminal loop deleted
tenecin 1, reduced tenecin 1 and tenecin 1 were chemically
synthesized and their activities were measured. N-terminal loop
deleted tenecin and reduced tenecin 1 did not show antibacterial
activity. Circular dichroism (CD) spectroscopy data revealed
that the K-helical content of tenecin 1 and the other proteins
increased in the presence of 50% (v/v) trifluoroethanol (TFE) and
the K-helical content of tenecin 1 was much higher than that of
the other proteins in buffer with or without 50% (v/v) TFE. These
results suggest that disulfide bridges are necessary for the
activity structure and the N-terminal loop plays an important
role in the increase of K-helix in the membrane mimetic
environment and the activity.
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1. Introduction
The insect defensin family, which had molecular weights of
3^4 kDa and three disul¢de bridges, showed potent bacterici-
dal activity against various Gram-positive bacteria and lesser
activity against Gram-negative bacteria [1^3]. The study of the
mechanism of sapecin and insect defensin A indicated that
these defensin proteins acted on the cytoplasmic membrane
by pore formation [4,5]. By NMR studies [6^8] the three-di-
mensional structure of the proteins in this family was obtained
in aqueous solution. As shown in Fig. 1A, the insect defensin
family shares a common structural feature of a short amphi-
pathic K-helix followed by a C-terminal antiparallel L-sheet
structure stabilized by two disul¢de bridges (named cysteine
stabilized K/L motif). Interestingly, the same structural motif
was found in the structure of scorpion toxins [9,10]. As this
structural motif was commonly used to maintain the di¡erent
function of insect defensin and scorpion toxin, this motif has
received attention as a sca¡old for protein engineering [11]. As
shown in Fig. 1B, aligned primary amino acid sequence of the
insect defensin family showed that the three disul¢de bridges
were conserved; three amino acids are between the two cys-
teines in the helix region and one amino acid between the two
cysteines in the L-sheet region and the general consensus se-
quence is C...CXXXC...C...CXC (X is any amino acid). How-
ever, many insect defensin proteins have a variable size and
amino acids in the region of the N-terminal loop especially.
The number of residues is from 6 to 17 between the two
cysteines in the N-terminal loop, suggesting that this region
may not be essential for antibacterial activity but speci¢city.
For example, both Aeshna defensin and Phormian defensin A
were active against Gram-positive bacteria, however, Aeshna
defensin with a short N-terminal loop showed more activity
against some of the Gram-positive bacteria strains than Phor-
mian defensin A with a long N-terminal loop [12]. However,
there is no study about the function of the N-terminal loop of
the insect defensin family for structure and activity.
In the present study, we chose tenecin 1 as a model protein
among the insect defensin family to investigate the function of
the N-terminal loop and disul¢de bridges. Tenecin 1, induced
in the hemolymph of larvae of coleopteran Tenebrio molitor,
had a very long N-terminal loop, the common structural fea-
ture named cysteine stabilized K/L motif and a potent bacter-
icidal activity against Gram-positive bacteria, especially me-
thicillin-resistant Staphylococcus aureus (MRSA) [13]. We
chemically synthesized reduced tenecin 1, tenecin 1 and N-
terminal loop deleted tenecin 1 and measured their activities
against Gram-positive bacteria. Tenecin 1 showed potent anti-
bacterial activity while reduced tenecin 1 and N-terminal loop
deleted tenecin 1 did not, which indicates that three disul¢de
bridges and the N-terminal loop are necessary for activity. By
CD spectroscopy study, three disul¢de bridges maintained the
ordered structure in bu¡er and helped to induce the structure
with high K-helical content in membrane mimetic environ-
ment. Also, the N-terminal loop played an important role in
the increase of K-helix in membrane mimetic environment,
which related to the activity.
2. Materials and methods
2.1. Peptide synthesis
Peptide was prepared by stepwise solid-phase synthesis on an Ap-
plied Biosystems model 431A automatic peptide synthesizer. The pep-
tide chain was assembled on the hydroxymethylphenoxy polystyrene
resin (HMP-resin) (Novabiochem, USA). The C-terminal amino acid
Fmoc-Arg(Pmc)-OH was manually coupled to the HMP resin. All
Fmoc-amino acid derivatives were purchased from Novabiochem.
The £uorenylmethoxycarbonyl (Fmoc) group was employed for the
protection of the K-amino group and the side chain protections were
triphenylmethyl (Trt) for Cys, Gln, Asn and His, tert-butyl (tBu) for
Thr, Glu, Ser and Asp, tert-butyloxycarbonyl (Boc) for Lys and
2,2,5,7,8-pentamethylchroman-6-sulfonyl (Pmc) for Arg. Cleavage of
the peptide from the resin was achieved by treatment with tri£uoro-
acetic acid (TFA)/thioanisole/ethanedithiol/H2O in the ratio of
80:5:2.5:5 (v/v) at room temperature for 12 h. After ¢ltration and
washing of resin by TFA, a gentle stream of nitrogen removed excess
TFA. Crude peptide was triturated with diethyl ether chilled at 320‡C
and then centrifuged at 3000 rpm for 10 min at 310‡C. The synthetic
peptide was puri¢ed by prep HPLC using a Vydac C-18 column.
Amino acid analysis and electrospray ionization (ESI) mass spectrom-
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etry on a Platform II (Micromass, UK) was used to characterize the
puri¢ed peptide.
2.2. Folding and peptide mapping
The puri¢ed synthetic peptides were reduced by 50 mM of DTT
(Aldrich, USA) in 10 mM phosphate bu¡er (pH 7.4) at 50‡C for 4 h
and puri¢ed by HPLC. For determination of the redox state of the
cysteine residue, the puri¢ed peptide was characterized by Ellman
assay and HPLC-mass spectrometer. Oxidation of linear tenecin
1 was carried out by the glutathione system (reviewed in [14]) and
disul¢de pairs of oxidized tenecin 1 were determined by the same
method as described for the characterization of sapecin B [15]. The
oxidized tenecin 1 (100 Wg) was digested with Lys-C (2 Wg) in a bu¡er
(50 Wl) containing 25 mM Tris-HCl, 1 mM EDTA, pH 6.8, at 35‡C
for 15 h and puri¢ed by HPLC. The peptide was further digested with
trypsin (3 Wg) in a bu¡er containing 0.2 M NH4HCO3 for 6 h at 30‡C.
The fragment was separated by HPLC and digested with thermolysin
(2 Wg) in a bu¡er containing 0.1 M Tris-HCl bu¡er, pH 8, for 24 h at
37‡C. Each puri¢ed peptide in this process was characterized by ESI
mass spectrometer to determine the connectivity of synthesized tene-
cin 1.
2.3. Antimicrobial assay
In vitro antimicrobial assay was done by a modi¢ed microdilution
technique [16,17] using 96-well microplates (Nunc, Denmark). Anti-
biotic medium 3 (M3; pH 7.0 at 25‡C, Difco) was used as antibacte-
rial assay medium. Freshly grown cells on antibiotic medium 3 agar
plate were suspended in physiological saline to 104 cells per 1 ml of
2U concentrated medium and used as the inoculum. Just before the
assay, solid samples were dissolved, added to the wells (100 Wl per
well) and the wells were serially diluted twofold. After inoculation
(100 Wl per well, 5U103 cells per ml), plates were incubated at 37‡C
for 24 h, and the absorbance at 620 nm was measured by an ELISA
reader (Spectra, Austria) to assess cell growth. Antifungal assay was
done in Sabraud-2% dextrose broth (SB; pH 5.6 at 25‡C, Merck) and
the plates were incubated at 30‡C for 24 h. The minimum inhibitory
concentration (MIC) was de¢ned as the concentration at which 100%
inhibition was observed. All MICs were determined from two inde-
pendent experiments performed in duplicate.
2.4. CD measurements
CD spectra were recorded on a J-715 spectropolarimeter (Jasco,
Japan) using a quartz cell path length of 1 mm at wavelengths ranging
from 190 to 250 nm. Tri£uoroethanol (TFE) was obtained from Al-
drich (Milwaukee, USA). The concentration of peptides was 2U1034
(g/ml) in 10 mM sodium phosphate bu¡er (pH 7.4) with or without
50% TFE (v/v). The CD spectrum was recorded at room temperature
and was obtained with a 0.5-nm bandwidth and a scan speed of 10
nm/min. Two scans were averaged to improve the signal-to-noise ra-
tio. The helicity of the peptide was determined from the mean residue
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Fig. 1. A: Molecular model of tenecin 1 built from the three dimensional structure of insect defensin A [24]. B: Primary structures of tenecin 1
[13] and related insect defensin family proteins [15,25^27]. Dashed lines indicated disul¢de bridges and gaps were introduced to align the maxi-
mal sequence homology.
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ellipticity ranging from 190 to 240 nm by the method of Green¢eld
and Fasman [18].
3. Results and discussion
3.1. Synthesis, folding and disul¢de bond assignment
To investigate the function of the N-terminal loop and di-
sul¢de bridges, tenecin 1, N-terminal loop deleted tenecin 1,
and reduced tenecin 1 were synthesized. Synthesized 43mer
peptide was puri¢ed by prep HPLC and characterized using
a mass spectrometer and amino acid analysis. The purity of
the synthesized peptide corresponding to reduced tenecin 1
was above 95% as measured by analytical HPLC. Oxidation
of this peptide performed by using the di¡erent ratios of oxi-
dized (GSSG)/reduced (GSH) glutathione provided a single
major peak of the product. The GSSG/GSH ratio correspond-
ing to 10:1 provided almost a single product. Mass spectrum
in Fig. 2 and Ellman assay con¢rmed the oxidation of the
protein. As shown in Table 1, the mass of oxidized protein
was in good agreement with the calculated mass of tenecin 1.
To assign the connectivity of the disul¢de bridge, the oxidized
protein was digested by enzyme, separated by reverse-phase
HPLC and characterized by mass spectrometer as described in
Section 2. As shown in Table 1, the measured mass of digested
fragments indicated that the oxidized protein was correctly
folded. N-terminal loop deleted tenecin 1 was prepared from
the deletion of the N-terminus in tenecin 1 by endopeptidase
rather than the oxidization of N-terminal deleted linear pro-
tein for the following reasons. First, generally, the deletion of
the N-terminal loop may have an e¡ect on the folding of the
protein [19,20]. Second, as the N-terminal truncated linear
tenecin 1 has ¢ve cysteine residues, capping of the fourth
cysteine may a¡ect the cysteine stabilized K/L sca¡old or fold-
ing. Digestion of tenecin 1 by aspartic protease provided two
peptides. The peptide corresponding to N-terminal loop de-
leted tenecin 1 was puri¢ed by HPLC. Mass spectrum con-
¢rmed that only residues 4^16 were selectively deleted in this
protein.
3.2. Antibacterial activity and conformation analysis
As shown in Table 2, chemically synthesized tenecin 1
showed the same antibacterial activity as shown in the liter-
ature [13]. However, reduced tenecin 1 and N-terminal loop
deleted tenecin 1 did not show antibacterial and antifungal
activity up to 100 Wg/ml. Many structure-activity studies
about antibacterial peptides indicate that an amphipathic K-
helical or L-sheet structure and net positive charge are funda-
mental factors for the activity (reviewed in [21]). As N-termi-
nal loop deletion or reduction of tenecin 1 maintains the net
positive charge, we can ¢nd the structure-activity relationship
of the protein. As membrane-active peptides act on the lipid
membrane, the structure in lipid membrane is important for
the interpretation of the activity (reviewed in [21]).
To get the conformation of each protein in bu¡er and lipid
membrane, CD spectra of each protein were measured in the
presence and absence of TFE, a well known membrane mim-
icking solvent [22,23]. TFE is known to induce the secondary
structure in peptides and proteins and stabilize the helical
structure in the native protein that has signi¢cant helical pro-
pensity [22]. As shown in Fig. 3, the CD spectrum of tenecin 1
measured in bu¡er exhibited double minimum bands at 208
and 227 nm, indicating the structure of the K-helix and L-
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Fig. 2. Mass spectrum of reduced tenecin 1 (A) and tenecin 1 (B).
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sheet. 21% of the K-helix and 35% of the L-sheet were calcu-
lated from this CD spectrum using the method of Green¢eld
and Fasman [18]. This result is consistent with our previous
molecular model of tenecin 1 built from the tertiary structure
of inset defensin A [24]. Reductions of three disul¢de bridges
changed the major conformation to the random coil in bu¡er
solution. N-terminal loop deleted tenecin 1 in bu¡er solution
formed an ordered secondary structure that was not well de-
¢ned. The deletion of the N-terminal loop had the same e¡ect
as deletion of the disul¢de bridge between the ¢rst cysteine
and the fourth cysteine. The two-disul¢de bridges between the
K-helix and L-sheet could not provide enough constraint for
the conformation of tenecin 1 maintained by three disul¢de
bridges.
The CD spectrum of tenecin 1 in the presence of 50% TFE
showed that the minimal band at 208 nm greatly increased in
this condition, indicating that the K-helical conformation
must be induced in the membrane environment. K-Helix and
L-sheet content were calculated to be 39% and 34%, respec-
tively. This result suggests that the random conformation of
the N-terminal loop changes to an K-helix in the presence of
TFE. The CD spectrum of N-terminal loop deleted tenecin 1
measured in the same condition indicates that even though
this protein adopts the conformation with the K-helix and
L-sheet, the K-helical content (10%) is even lower than that
of tenecin 1 obtained in bu¡er and the L-sheet content is
calculated to be 55%. In the N-terminal loop deleted tenecin
1, two disul¢de bridges between the K-helix and L-sheet could
provide some constraint for the ordered structure in bu¡er
and helped to stabilize the structure with high L-sheet content
in the presence of 50% (v/v) TFE. But this structure is not
satisfactory for the structural requirement for activity because
of the lack of K-helix. We suspect that the lack of K-helix in
the presence of TFE must be due to the deletion of the N-
terminal loop.
When we consider the structural change of tenecin 1 in
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Table 2
Antimicrobial activity of tenecin 1 and its analogs
Strain MIC (Wg/ml)
Staphylococcus
aureus
ATCC 6538
MRSA (methicillin
resistant S. aureus)
Micrococcus luteus
ATCC 9341
Escherichia coli
ATCC 2592
Pseudomonas
aeruginosa
ATCC 9027
Candida albicans
ATCC 36232
Tenecin 1 6.25 25 3.12 s 100 s 100 s 100
Reduced tenecin 1 s 100 s 100 s 100 s 100 s 100 s 100
N-terminal loop
deleted tenecin 1
s 100 s 100 s 100 s 100 s 100 s 100
Table 1
Molecular mass of tenecin 1, its analog, and digested fragments
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bu¡er and 50% TFE, this protein expected to have a large
constraint by three disul¢de bridges had some £exibility and
adopted a more K-helical structure in the presence of 50%
(v/v) TFE. In the presence of TFE, reduced tenecin 1, which
has a random conformation in bu¡er, adopted an ordered
structure with 20% K-helix and 22% L-sheet but was not ac-
tive. Induced structure of reduced tenecin 1 may not be
enough for the interaction with the lipid membrane to be
biologically active because the K-helical content is much lower
than that of tenecin 1 obtained in the presence of TFE. This
result indicated that three disul¢de bridges in tenecin 1 stabi-
lized the ordered structure in bu¡er and introduced con-
straints for helping the induction of the structure with high
K-helix in lipid membrane, which must be a critical function
of the disul¢de bridge for activity. Natori et al. [15] also
showed that disul¢de bridges of sapecin among the insect
defensin family were necessary for antibacterial activity.
In conclusion, tenecin 1 adopted a higher K-helical structure
in the presence of 50% (v/v) TFE and three disul¢de bridges
which were essential for the activity, helped to induce the
higher K-helical structure in the membrane mimetic environ-
ment. The N-terminal loop also played an important role in
the increase of K-helix in the membrane mimetic environment,
which was necessary for the activity.
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Fig. 3. A: CD spectra of tenecin 1 in bu¡er with or without 50%
(v/v) TFE. 999, in bu¡er; ^ ^ ^, in the presence of TFE. B: CD
spectra of reduced tenecin 1 and N-terminal loop deleted tenecin 1
in bu¡er with or without 50% (v/v) TFE. ^ W W ^, Reduced tenecin 1
in bu¡er; W W W, reduced tenecin 1 in the presence of TFE; ^ ^ ^, N-
terminal loop deleted tenecin 1 in bu¡er; 999, N-terminal loop
deleted tenecin 1 in the presence of TFE. Spectra of the proteins
(200 Wg/ml) in bu¡er with or without TFE 50% (v/v) were recorded
on a Jasco J-715 spectropolarimeter in 1-mm cell at 22‡C.
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